Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic Drugs A Systematic Review and Meta-Analysis

被引:143
|
作者
Kesselheim, Aaron S. [1 ,2 ]
Stedman, Margaret R. [1 ,2 ]
Bubrick, Ellen J. [2 ,3 ]
Gagne, Joshua J. [1 ,2 ]
Misono, Alexander S. [1 ,2 ]
Lee, Joy L. [1 ,2 ]
Brookhart, M. Alan [4 ]
Avorn, Jerry [1 ,2 ]
Shrank, William H. [1 ,2 ]
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Neurol, Div Epilepsy, Boston, MA 02115 USA
[4] UNC Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
基金
美国医疗保健研究与质量局;
关键词
SUBSTITUTION; BIOAVAILABILITY; CARBAMAZEPINE; EPILEPSY; DISSOLUTION; IDENTIFICATION; LAMOTRIGINE; MEDICATION; PATIENT; EVENTS;
D O I
10.2165/10898530-000000000-00000
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The automatic substitution of bioequivalent generics for brand-name antiepileptic drugs (AEDs) has been linked by anecdotal reports to loss of seizure control. Objective: To evaluate studies comparing brand-name and generic AEDs, and determine whether evidence exists of superiority of the brand-name version in maintaining seizure control. Data Sources: English-language human studies identified in searches of MEDLINE, EM BASE and International Pharmaceutical Abstracts (1984 to 2009). Study Selection: Randomized controlled trials (RCTs) and observational studies comparing seizure events or seizure-related outcomes between one brand-name AED and at least one alternative version produced by a distinct manufacturer. Data Extraction: We identified 16 articles (9 RCTs, 1 prospective non-randomized trial, 6 observational studies). We assessed characteristics of the studies and, for RCTs, extracted counts for patients whose seizures were characterized as 'controlled' and 'uncontrolled'. Data Synthesis: Seven RCTs were included in the meta-analysis. The aggregate odds ratio (n = 204) was 1.1(95% CI 0.9, 1.2), indicating no difference in the odds of uncontrolled seizure for patients on generic medications compared with patients on brand-name medications. In contrast, the observational studies identified trends in drug or health services utilization that the authors attributed to changes in seizure control. Conclusions: Although most RCTs were short-term evaluations, the available evidence does not suggest an association between loss of seizure control and generic substitution of at least three types of AEDs. The observational study data may be explained by factors such as undue concern from patients or physicians about the effectiveness of generic AEDs after a recent switch. In the absence of better data, physicians may want to consider more intensive monitoring of high-risk patients taking AEDs when any switch occurs.
引用
收藏
页码:605 / 621
页数:17
相关论文
共 50 条
  • [1] Seizure Outcomes Following the Use of Generic versus Brand-Name Antiepileptic DrugsA Systematic Review and Meta-Analysis
    Aaron S. Kesselheim
    Margaret R. Stedman
    Ellen J. Bubrick
    Joshua J. Gagne
    Alexander S. Misono
    Joy L. Lee
    M. Alan Brookhart
    Jerry Avorn
    William H. Shrank
    Drugs, 2010, 70 : 605 - 621
  • [2] Brand-Name Versus Generic Drugs
    Manning, Richard
    Smith, Richard
    HEALTH AFFAIRS, 2011, 30 (10) : 2027 - 2027
  • [3] Are Generic Drugs Used in Cardiology as Effective and Safe as Their Brand-name Counterparts? A Systematic Review and Meta-analysis
    Leclerc, Jacinthe
    Thibault, Magalie
    Gonella, Jennifer Midiani
    Beaudoin, Claudia
    Sampalis, John
    CIRCULATION, 2020, 141
  • [4] Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis
    Jacinthe Leclerc
    Magalie Thibault
    Jennifer Midiani Gonella
    Claudia Beaudoin
    John Sampalis
    Drugs, 2020, 80 : 697 - 710
  • [5] Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease A Systematic Review and Meta-analysis
    Kesselheim, Aaron S.
    Misono, Alexander S.
    Lee, Joy L.
    Stedman, Margaret R.
    Brookhart, M. Alan
    Choudhry, Niteesh K.
    Shrank, William H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21): : 2514 - 2526
  • [6] Are Generic Drugs Used in Cardiology as Effective and Safe as their Brand-name Counterparts? A Systematic Review and Meta-analysis
    Leclerc, Jacinthe
    Thibault, Magalie
    Gonella, Jennifer Midiani
    Beaudoin, Claudia
    Sampalis, John
    DRUGS, 2020, 80 (07) : 697 - 710
  • [7] Comparative effectiveness of generic versus brand-name antiepileptic medications
    Gagne, Joshua J.
    Kesselheim, Aaron S.
    Choudhry, Niteesh K.
    Polinski, Jennifer M.
    Hutchins, David
    Matlin, Olga S.
    Brennan, Troyen A.
    Avorn, Jerry
    Shrank, William H.
    EPILEPSY & BEHAVIOR, 2015, 52 : 14 - 18
  • [8] Generic versus brand-name drugs used in cardiovascular diseases
    Manzoli, Lamberto
    Flacco, Maria Elena
    Boccia, Stefania
    D'Andrea, Elvira
    Panic, Nikola
    Marzuillo, Carolina
    Siliquini, Roberta
    Ricciardi, Walter
    Villari, Paolo
    Ioannidis, John P. A.
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2016, 31 (04) : 351 - 368
  • [9] Generic versus brand-name drugs used in cardiovascular diseases
    Lamberto Manzoli
    Maria Elena Flacco
    Stefania Boccia
    Elvira D’Andrea
    Nikola Panic
    Carolina Marzuillo
    Roberta Siliquini
    Walter Ricciardi
    Paolo Villari
    John P. A. Ioannidis
    European Journal of Epidemiology, 2016, 31 : 351 - 368
  • [10] Generic versus brand-name cardiovascular drugs: a remarkable update
    Flacco, Maria Elena
    Fragassi, Giorgia
    Manzoli, Lamberto
    EPIDEMIOLOGY BIOSTATISTICS AND PUBLIC HEALTH, 2015, 12 (04)